Literature DB >> 1580655

Counting the nucleolar organizer region-associated proteins is a prognostic clue of malignant melanoma.

C Gambini1, S Casazza, L Borgiani, M Canepa, S Rovida, F Rongioletti, A Rebora.   

Abstract

BACKGROUND AND
DESIGN: The nucleolar organizer regions (NORs) are chromosomal loops of DNA to which acidic proteins are associated that are seen by silver staining as black dots within the nucleoli (hereafter, these silver-staining NORs will be referred to as AgNORs). As their size and number reflect cell and nuclear activity, their counting in paraffin sections is regarded as a useful tool for diagnosing and prognosing malignant tumors. We counted AgNORs in 98 patients with stage I melanoma, followed up to an average of 73 months, to verify whether the number of AgNORs is of prognostic value.
RESULTS: The number of AgNORs averaged 2.792 +/- 0.901 in the 64 patients without metastases and 4.889 +/- 1.403 in the 34 with metastases. In patients with counts higher than 3.62, there was an 82% probability of metastases developing.
CONCLUSION: The technique is fast, simple, and reproducible with easily available reagents and standard light microscopy. In our population, AgNOR counts constituted a more accurate prognostic indicator than Clark's level and Breslow's thickness. Confirmation in a new population is needed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1580655

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  2 in total

1.  Predictive value of argyrophilic nucleolar-organizer-region-associated proteins in bladder cancer, using cell-imprint preparations.

Authors:  M Masuda; Y Takano; M Iki; S Jinza; S Noguchi; Y Kubota; M Hosaka
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Increased expression of a nucleolar Nop5/Sik family member in metastatic melanoma cells: evidence for its role in nucleolar sizing and function.

Authors:  K Nakamoto; A Ito; K Watabe; Y Koma; H Asada; K Yoshikawa; Y Shinomura; Y Matsuzawa; H Nojima; Y Kitamura
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.